The chemistry of metal phosphonates has been progressing fast with the addition of new materials that possess novel structural features and new properties, occasionally in a cooperative manner. In this paper, we report a new family of functional lanthanide-carboxyphosphonate materials. Specifically, the lanthanide is La, Ce, Pr, Sm, Eu, Gd, Tb, or Dy and the carboxyphosphonate ligand is 2-hydroxyphosphonoacetic acid ( H 3 H P A ) . A l l r e p o r t e d L n H P A c o m p o u n d s , Ln 3 (H 0.75 O 3 PCHOHCOO) 4 •xH 2 O (x = 15−16), crystallize in the orthorhombic system. Two types of structures were isolated: series I and II polymorphs. For both series, the three-dimensional (3D) open frameworks result from the linkage of similar organo-inorganic layers, in the ac-plane, by central lanthanide cations, which yield trimeric units also found in other metal-HPA hybrids. Large oval-shaped 1D channels are formed by the spatial separation of the layers along the b-axis and filled with lattice water molecules. LnHPA materials undergo remarkable crystalline-to-amorphous-to crystalline transformations upon dehydration and rehydration cycles, as confirmed by thermodiffraction and NMR spectroscopy. The highest proton conductivity was observed for GdHPA (series II), 3.2 × 10 −4 S cm −1 at 98% RH and T = 21°C. The dehydration−rehydration chemistry was also followed by photoluminescence spectroscopy. It was shown that loss and reuptake of water molecules are accompanied by clear changes in the photoluminescence spectra and lifetimes of the Eu analog (series II). Our present results reveal a wide family of wellcharacterized, multifunctional lanthanide-based phosphonate 3D-structured metal−organic frameworks (MOFs) that show reversible crystalline-to-amorphous-to-crystalline transformations and, at the same time, exhibit high proton conductivity.

Metal-bisphosphonates are self-sacrificial controlled delivery systems that achieve ultra-long release of anti-osteoporotic bisphosphonate drugs.

The synthesis, structural characterization, luminescence properties, and proton conduction performance of a new family of isostructural cationic 2D layered compounds are reported. These have the general formula [Ln(H4NMP)(H2O)2]Cl·2H2O [Ln = La(3+), Pr(3+), Sm(3+), Eu(3+), Gd(3+), Tb(3+), Dy(3+), Ho(3+), H6NMP = nitrilotris(methylphosphonic acid)], and contain Cl(-) as the counterion. In the case of Ce(3+), a 1D derivative, [Ce2(H3NMP)2(H2O)4]·4.5H2O, isostructural with the known lanthanum compound has been isolated by simply crystallization at room temperature. The octa-coordinated environment of Ln(3+) in 2D compounds is composed by six oxygen atoms from three different ligands and two oxygens from each bound water. Two of the three phosphonate groups act as both chelating and bridging linkers, while the third phosphonate group acts solely as a bridging moiety. The materials are stable at low relative humidity at less at 170 °C. However, at high relative humidity transform to other chloride-free phases, including the 1D structure. The proton conductivity of the 1D materials varies in a wide range, the highest values corresponding to the La derivative (σ ≈ 2 × 10(-3) S·cm(-1) at RH 95% and 80 °C). A lower proton conductivity, 3 × 10(-4) S·cm(-1), was measured for [Gd(H4NMP)(H2O)2]Cl·2H2O at 80 °C, which remains stable under the work conditions used. Absorption and luminescence spectra were recorded for selected [Ln(H4NMP)(H2O)2]Cl·2H2O compounds. In all of them, the observed transitions are attributed solely to f-f transitions of the lanthanide ions present, as the H4NMP(2-) organic group has no measurable absorption or luminescence properties.

(Poly)phosphonic acids constitute an exciting family of phosphorus compounds. One of the attractive attributes of these molecules is the rich chemistry of the phosphonate moiety, and, in particular, its high affinity for metal ions and mineral surfaces. Whether the phosphonate group belongs to a “small” molecule or to a polymeric matrix, phosphonate-containing compounds have found a phalanx of real-life applications. Herein, we address a special category of phosphorus compounds called bisphosphonates (BPs, a.k.a. “-dronates”) and also phosphonate containing polymers. The success of BPs in mitigating osteoporosis notwithstanding, these “-dronate” drugs present a number of challenges. Nevertheless, the main drawback of BPs is their limited oral bioavailability. It is, therefore, imperative to design and fabricate “smart” systems that allow controlled delivery of the active BP agent. Here, easy-to-prepare drug delivery systems are presented based on silica gels. These have been synthesized, characterized, and studied as hosts in the control release of several BP drugs. They exhibit variable release rates and final % release, depending on the nature of bisphosphonate (side-chain length, hydro-philicity/-phobicity, water-solubility), cations present, pH and temperature. These gels are robust, injectable, re-loadable and re-usable. Furthermore, alternative drug delivery systems are presented that are based on metal-organic frameworks (MOFs). In these biologically acceptable inorganic metal ions have been incorporated, together with BPs as the organic portion. These materials have been synthesized, characterized, and studied for the self-sacrificial release (by pH-driven dissolution) of the BP active ingredient. Several such materials were prepared with a variety of bisphosphonate drugs. They exhibit variable release rates and final % release, depending on the actual structure of the metal-bisphosphonate material. Lastly, we will present the use of phosphonate-grafted polymers as scale inhibitors for water treatment applications.